搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Rhodococcus opacus NADH-quinone oxidoreductase subunit N (nuoN), partial CSB-YP499169RLN
CSB-EP499169RLN
CSB-BP499169RLN
CSB-MP499169RLN
CSB-EP499169RLN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodococcus opacus 50S ribosomal protein L23 (rplW) CSB-YP499170RLN
CSB-EP499170RLN
CSB-BP499170RLN
CSB-MP499170RLN
CSB-EP499170RLN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodococcus opacus 30S ribosomal protein S8 (rpsH) CSB-YP499171RLN
CSB-EP499171RLN
CSB-BP499171RLN
CSB-MP499171RLN
CSB-EP499171RLN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodococcus opacus 30S ribosomal protein S13 (rpsM) CSB-YP499172RLN
CSB-EP499172RLN
CSB-BP499172RLN
CSB-MP499172RLN
CSB-EP499172RLN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodococcus opacus UPF0182 protein ROP_64500 (ROP_64500), partial CSB-YP499173RLN
CSB-EP499173RLN
CSB-BP499173RLN
CSB-MP499173RLN
CSB-EP499173RLN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodococcus opacus NH (3)-dependent NAD (+) synthetase CSB-YP499174RLN
CSB-EP499174RLN
CSB-BP499174RLN
CSB-MP499174RLN
CSB-EP499174RLN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodococcus opacus Aspartyl/glutamyl-tRNA (Asn/Gln) amidotransferase subunit B, partial CSB-YP499175RLN
CSB-EP499175RLN
CSB-BP499175RLN
CSB-MP499175RLN
CSB-EP499175RLN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodococcus opacus Formamidopyrimidine-DNA glycosylase (mutM) CSB-YP499176RLN
CSB-EP499176RLN
CSB-BP499176RLN
CSB-MP499176RLN
CSB-EP499176RLN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodococcus opacus 4-hydroxy-3-methylbut-2-en-1-yl diphosphate synthase (ispG) CSB-YP499177RLN
CSB-EP499177RLN
CSB-BP499177RLN
CSB-MP499177RLN
CSB-EP499177RLN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodococcus opacus 30S ribosomal protein S15 (rpsO) CSB-YP499178RLN
CSB-EP499178RLN
CSB-BP499178RLN
CSB-MP499178RLN
CSB-EP499178RLN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodococcus opacus Transcriptional repressor NrdR (nrdR) CSB-YP499179RLN
CSB-EP499179RLN
CSB-BP499179RLN
CSB-MP499179RLN
CSB-EP499179RLN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodococcus opacus Holliday junction ATP-dependent DNA helicase RuvB (ruvB) CSB-YP499180RLN
CSB-EP499180RLN
CSB-BP499180RLN
CSB-MP499180RLN
CSB-EP499180RLN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodococcus opacus N utilization substance protein B homolog (nusB) CSB-YP499181RLN
CSB-EP499181RLN
CSB-BP499181RLN
CSB-MP499181RLN
CSB-EP499181RLN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodococcus opacus UPF0042 nucleotide-binding protein ROP_69550 (ROP_69550) CSB-YP499182RLN
CSB-EP499182RLN
CSB-BP499182RLN
CSB-MP499182RLN
CSB-EP499182RLN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodococcus opacus Acetaldehyde dehydrogenase 1 (cmtH) CSB-YP499183RLN
CSB-EP499183RLN
CSB-BP499183RLN
CSB-MP499183RLN
CSB-EP499183RLN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodococcus opacus Acetaldehyde dehydrogenase 2 (ROP_37350) CSB-YP499184RLN
CSB-EP499184RLN
CSB-BP499184RLN
CSB-MP499184RLN
CSB-EP499184RLN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodococcus opacus 2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase (ispD) CSB-YP499185RLN
CSB-EP499185RLN
CSB-BP499185RLN
CSB-MP499185RLN
CSB-EP499185RLN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodococcus opacus 4-hydroxy-2-oxovalerate aldolase 6 (ROP_pROB02-02240) CSB-YP499186RLN
CSB-EP499186RLN
CSB-BP499186RLN
CSB-MP499186RLN
CSB-EP499186RLN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus pneumoniae Ribonuclease HIII (rnhC) CSB-YP499187FMX
CSB-EP499187FMX
CSB-BP499187FMX
CSB-MP499187FMX
CSB-EP499187FMX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus pneumoniae Elongation factor P (efp) CSB-YP499188FMX
CSB-EP499188FMX
CSB-BP499188FMX
CSB-MP499188FMX
CSB-EP499188FMX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過(guò)多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過(guò)程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過(guò)多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過(guò)程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見(jiàn)問(wèn)題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問(wèn),涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>